Article Text

Download PDFPDF

Routine use of oxygen in the treatment of myocardial infarction: systematic review
Free
  1. M Wijesinghe1,
  2. K Perrin1,
  3. A Ranchord2,
  4. M Simmonds2,
  5. M Weatherall3,
  6. R Beasley1,4
  1. 1
    Medical Research Institute of New Zealand, Wellington, New Zealand
  2. 2
    Capital and Coast District Health Board, Wellington, New Zealand
  3. 3
    University of Otago Wellington, Wellington, New Zealand
  4. 4
    University of Southampton, Southampton, UK
  1. Professor R Beasley, Medical Research Institute of New Zealand, PO Box 10055, Wellington 6143, New Zealand; Richard.Beasley{at}mrinz.ac.nz

Abstract

Context: International guidelines recommend the routine use of oxygen therapy in the treatment of myocardial infarction (MI).

Objective: To undertake a systematic review and meta-analysis of randomised placebo-controlled trials of oxygen therapy in MI.

Data sources: Medline, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, EMBASE and CINHAL.

Study selection: Randomised placebo-controlled trials of oxygen therapy in MI.

Data extraction: The primary clinical outcome was mortality.

Results: Two of 51 potential studies met the inclusion criteria. The one study with substantive clinical outcome data reported that in uncomplicated MI, high-flow oxygen was associated with a non-significant increased risk of death (risk ratio 2.9, 95% CI 0.8 to 10.3, p = 0.08) and a greater serum aspartate aminotransferase level (difference 19.2 IU/ml, 95% CI 0 to 38.4, p = 0.05) than room air.

Conclusion: The limited evidence that does exist suggests that the routine use of high-flow oxygen in uncomplicated MI may result in a greater infarct size and possibly increase the risk of mortality.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • MWi is a Wellington Hospitals and Health Foundation Research Fellow and KP is a Health Research Council of New Zealand Training Fellow. MWi and KP undertook the systematic review, MWe undertook the statistical analyses and all authors reviewed the studies identified and contributed to writing the manuscript.

  • Competing interests: None.